CIA
MEDP icon

Concurrent Investment Advisors’s Medpace MEDP Stock Holding History

Concurrent Investment Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,151
Closed -$646K – 2001
2025
Q4 		$646K Buy
+1,151
New +$653K 0.01% 1034

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Concurrent Investment Advisors's MEDP Position: Q1 2026 in Review

Concurrent Investment Advisors sold out of Medpace (MEDP) in Q1 2026, closing a stake of 1,151 shares — an estimated $646K sold.

Concurrent Investment Advisors first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $646K in Q4 2025. 730 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Concurrent Investment Advisors reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Concurrent Investment Advisors sold 1,151 Medpace shares in Q1 2026, an estimated $646K.
  • Concurrent Investment Advisors first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
  • Concurrent Investment Advisors's Medpace position peaked at $646K in Q4 2025.
  • 730 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.